Unlock instant, AI-driven research and patent intelligence for your innovation.

Histone deacetylase inhibitor (E)-3-(2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-yl)acetamido)-N-hydroxy-butyl-2-enamide and its preparation method and use

A chlorobenzoyl and deacetylase technology, which is applied in anti-inflammatory agents, drug combinations, antiviral agents, etc., can solve problems such as difficult absorption, poor pharmacokinetic properties, and short half-life

Active Publication Date: 2016-02-24
QINGDAO UNIV
View PDF5 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, many compounds currently in clinical research are not very effective, although they have shown excellent activity in preclinical studies
However, the marketed HDAC inhibitors (SAHA and FK228) have poor efficacy in the treatment of solid tumors, and they also have the disadvantages of short half-life, poor absorption and poor pharmacokinetic properties

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Histone deacetylase inhibitor (E)-3-(2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-yl)acetamido)-N-hydroxy-butyl-2-enamide and its preparation method and use
  • Histone deacetylase inhibitor (E)-3-(2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-yl)acetamido)-N-hydroxy-butyl-2-enamide and its preparation method and use
  • Histone deacetylase inhibitor (E)-3-(2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-yl)acetamido)-N-hydroxy-butyl-2-enamide and its preparation method and use

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0016] The preparation method of described compound, reaction steps and reaction formula are as follows:

[0017] The preparation method comprises the following steps:

[0018] Synthetic route: using indomethacin as raw material, first condense with methyl 3-aminocrotonate, then react with hydroxylamine potassium nucleophile, and finally obtain the final product; the reaction formula is as follows:

[0019] synthetic route:

[0020]

[0021] Reagents in the reaction formula of the above synthetic route 2: (1) methyl 3-aminocrotonate, O-benzotriazole-N,N,N',N'-tetramethyluronium tetrafluoroboric acid, triethylamine , dichloromethane; (2) potassium hydroxylamine, anhydrous methanol;

[0022] Preparation of the intermediate of the histone deacetylase inhibitor, the intermediate is: (E)-methyl 3-(2-(1-(4-chlorobenzoyl)-5-methoxy-2- Methyl-1hydro-indol-3-yl)acetamido)but-2-enoate.

[0023] Due to the high homology of the catalytic center of each subtype of zinc ion-dependent...

Embodiment 1

[0044] Synthesis of compounds of the present invention

[0045] synthetic route:

[0046] (E)-Methyl 3-(2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1hydro-indol-3-yl)acetamido)butan-2 -enoate

[0047] Indomethacin (1.97g, 5mmol) was dissolved in 50mL tetrahydrofuran, triethylamine (0.55g, 5.5mmol) was added, O-benzotriazole-N,N,N',N'-tetramethyl Urea tetrafluoroboric acid (TBTU) (1.8 g, 5.5 mmol). After reacting at room temperature for 20 minutes, methyl 3-aminocrotonate (1.8 g, 5 mmol) was added, followed by triethylamine (0.5 g, 5 mmol). After reacting at room temperature for 6 hours, distill off the tetrahydrofuran in the reaction liquid, dissolve the product with ethyl acetate, wash with 1 mol / L citric acid solution, saturated sodium bicarbonate solution, and saturated saline respectively three times, and dry over anhydrous magnesium sulfate. , The solvent was evaporated to dryness to obtain a crude product, which was recrystallized from ethyl acetate to obtain 1.37 g ...

Embodiment 2

[0051] Example 2 Target compound inhibits histone deacetylase activity test (Invitro)

[0052] The fluorescent analysis method of histone deacetylase (HDACs) activity is mainly divided into two steps: the first step is to use a lysine HDACs fluorescent substrate (Boc-Lys(acetyl)-AMC) containing an acetylated side chain, and use Hela cell extract samples of protein deacetylases (including HDAC1, HDAC2, HDAC3 and HDAC8) were incubated to deacetylate and activate substrates. In the second step, trypsin is used to hydrolyze Boc-Lys-AMC to generate AMC, a fluorescent group (ie, a chromophore), and the fluorescence intensity is measured at the emission wavelength / excitation wavelength (390nm / 460nm), so that according to the inhibitor group and control The inhibition rate was calculated from the fluorescence intensity of each group, and the IC50 value was calculated. For the principle of enzyme activity test, please refer to the relevant content of this patent specification. The ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of pharmaceutical chemistry and relates to a histone deacetylase inhibitor and its preparation method and use. The invention provides the histone deacetylase inhibitor with strong effects and relates to the compound with a structural formula (I) and its cis- and trans-isomers, pharmaceutically acceptable salts, solvates and prodrugs. The invention also relates to a pharmaceutical composition of the compound with a structural formula (I) and its use in pharmacy. The histone deacetylase inhibitor can effectively treat histone deacetylase activity abnormal expression-caused diseases.

Description

technical field [0001] The invention belongs to the technical field of medicinal chemistry, in particular to histone deacetylase inhibitor (E)-3-(2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl- 1H-indol-3-yl)acetamido)-N-hydroxybut-2-enamide and its preparation method and application. Background technique [0002] Histone deacetylases (HDACs) are a class of hydrolases with complex functions. In the nucleus, nucleosomes, composed of histone octamers wrapped around DNA strands, are the structural units of chromosomes. Histone deacetylases (HDACs) can attach lysine residues in histones to amino groups The acetyl group of the protein is hydrolyzed (such as reaction formula I), which leads to an increase in the positive charge density of histone, which in turn causes the affinity of histone to negatively charged DNA to be enhanced, and gene transcription is inhibited, (see Christian, A.H., et al.Curr. Opin. Chem. Biol., 1997, 1,300; Kouzarides, T., Curr. Opin. Genet. Dev., 1999, 9, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D209/26A61K31/405A61P35/00A61P25/28A61P31/12A61P29/00A61P3/10
CPCC07D209/26
Inventor 张磊韩彦弢边江张剑徐文芳
Owner QINGDAO UNIV